Navigation Links
Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients
Date:4/18/2013

ngs and systemic toxicities, limit its use in a chronic setting. In contrast to the established treatment of Pseudomonas aeruginosa lung infection with inhaled antibiotics, there is no FDA-approved inhaled antibiotic treatment available for MRSA lung infection.

Savara's Phase 2 clinical trial is a randomized, double-blind, placebo-controlled study in 80 CF patients at 22 CF centers nationwide. Patients will receive either 32 mg or 64 mg doses of AeroVanc or a corresponding placebo twice daily for 28 days. The primary objective of the study is to evaluate the efficacy of AeroVanc in reducing the quantity of MRSA colony forming units in the sputum cultures. The secondary objectives include evaluation of the efficacy of AeroVanc in improving lung function, reducing respiratory symptoms reported by the patients, and reducing the use of other antibiotics. Study results are expected in the first quarter of 2014.

"We are encouraged by the recent FDA approval of Novartis' dry-powder TOBI Podhaler for Pseudomonas aeruginosa infections in CF patients. An inhaled dry powder form of vancomycin for MRSA infection will be a logical addition to this and other treatment options available for CF patients," said Rob Neville , CEO of Savara Pharmaceuticals. "We are further encouraged by the strong interest and support of key opinion leaders, and the feedback that AeroVanc is exactly what the CF care community has been waiting for."  

Details of the AeroVanc Phase 2 study can be found at www.clinicaltrials.gov (study identifier NCT01746095).

About AeroVanc

Intravenous vancomycin is the antibiotic of choice for MRSA-related bronchopneumonia, however, the burden of IV administration, poor penetration into the lungs and systemic toxicities limit its use in a chronic setting. AeroVanc (vancomycin hydrochloride inhalation powder) is a proprietary inhaled dry
'/>"/>

SOURCE Savara Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tech Coast Angels Contributes More Than $3 Million to $16 Million Savara Pharmaceuticals Series B
2. Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
3. Savara Pharmaceuticals AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients
4. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
5. Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
6. Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013
7. Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
8. Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
9. JHP Pharmaceuticals to Produce Supplies of Biologic Drug Product for Late-Phase Clinical Trials
10. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
11. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Johnson & Johnson (NYSE: JNJ ... third party to review requests made to the Janssen ... for compassionate use of its investigational medicines. This new ... a single Janssen investigational medicine and, if successful, will ... across Johnson & Johnson. In keeping with ...
(Date:5/6/2015)... , May 6, 2015  Zimmer Holdings, Inc. (NYSE and ... that it will be presenting at the Bank of America ... hotel in Las Vegas, Nevada on ... A live webcast of the presentation can be accessed ... webcast will be archived for replay following the conference. ...
(Date:5/6/2015)... 6, 2015  The fairness of the proposed acquisition ... Alexion Pharmaceuticals, Inc. ("Alexion") is being investigated by WeissLaw ... for possible breaches of fiduciary duty and other violations ... for agreeing to sell the Company to Alexion.  On ... for Alexion to acquire GEVA in a transaction valued ...
Breaking Medicine Technology:Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 2Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 3Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 4Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 5WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2
... Radient Pharmaceuticals Corporation (OTCQX: RXPC.PK - News ... developer and marketer of cancer tests, today announces it ... in Taipei, Taiwan. Previously, Radient,s agreement with ... Radient,s flagship product Onko-Sure® cancer test in Taiwan.  Radient ...
... Dec. 21, 2011  Shareholders of Medco Health Solutions, Inc. (NYSE: ... Express Scripts. (Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO ) ... vote present in person or by proxy at a special ... Merger dated July 20, 2011 by a margin of 99 ...
Cached Medicine Technology:Radient Pharmaceuticals Corporation Expands Distribution of Onko-Sure® in Asia; Receives Payment on First Order of 60 Kits 2Radient Pharmaceuticals Corporation Expands Distribution of Onko-Sure® in Asia; Receives Payment on First Order of 60 Kits 3Medco Shareholders Approve Merger With Express Scripts 2
(Date:5/6/2015)... MJNational LLC strengthens its consultant agreement ... Bizcard ™ platform. This exciting new SMS platform creates ... Sales / Services. Now you can reach out ... products, services and ticker symbol through an easy to ... LLC will provide managed support and services to advance ...
(Date:5/6/2015)... Sulphur Springs, Texas (PRWEB) May 06, 2015 ... the stages of the HIMSS EMR Adoption Model, ... remove paper, improve patient engagement and automate processes. ... had transitioned from paper-driven to electronic workflows, patient ... to hard copies of consents. With HIMSS Stage ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child neglect, ... in Florida while under the influence of Flakka, according to ... released by CBS4’s Peter D’Oench records Doby distraught in a ... around one year old. The drug treatment center in Florida ... named. The residents polled by CBS Miami express concern about ...
(Date:5/6/2015)... Va. (PRWEB) May 06, 2015 ... in the state of Virginia to acquire Intuitive ... surgical robot. The system upgrade includes enhanced surgical ... minimally invasive procedures across a wide spectrum of ... options, reduced pain and quicker recovery times. , ...
(Date:5/6/2015)... Baptist Medical Center Jacksonville and the ... Florida and southeast Georgia region offering MAKOplasty® Hip ... total hip replacement surgery performed using the RIO® ... enables the accurate alignment and positioning of implants. ... partial knee resurfacing using the RIO system since ...
Breaking Medicine News(10 mins):Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 2Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 3Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4
... researchers report 80 percent success with their method, , ... that they,ve developed ways to detect 80 percent of ... more than one in 10 women who give birth. ... would make it possible to intervene to prevent it ...
... FAIRFAX, Va.The Society of Interventional Radiology Foundation recently ... a future scholarship fund for interventional radiology fellows ... dedicated to advancing the clinical needs of interventional ... conducting pivotal basic and clinical trials research. ...
... 2009 Late-breaking data from SPIRIT IV, a large-scale ... shows that an everolimus-eluting stent demonstrated enhanced safety and ... artery lesions when compared to a paclitaxel-eluting stent, and ... drug-eluting stents without sacrificing safety. Unlike similar ...
... conducted by Dr. Eric Blough and his colleagues at ... pain reliever acetaminophen may help prevent age-associated muscle loss ... may affect the regulation of protein kinase B (Akt), ... regulation of cellular survival, proliferation and metabolism. The ...
... influenza could slow growth in key industries and stall already-weak ... says a health economist in the University of Alabama at ... vitally important sectors in the economy of many U.S. cities ... the spread of the virus, consumers and businesses may respond ...
... ... External services for pharmaceutical firms have shown consistent growth in recent ... The global share of biotechnology services spending is in the billions ... of high-quality external services available to pharma ranges from supportive IT, ...
Cached Medicine News:Health News:Predicting Postpartum Depression May Be Possible 2Health News:Society of Interventional Radiology Foundation receives $1 million legacy gift 2Health News:SPIRIT IV trial shows everolimus stent sets new standard for event-free survival 2Health News:Research shows safe dosages of common pain reliever may help prevent conditions related to aging 2Health News:Swine flu could wreak more havoc on US economy, says UAB economist 2Health News:Cambridge Healthtech Institute and Bio-IT World Launch a New eNewsletter: Pharma Services News 2
... duet Signature Series multipurpose gamma ... FDG imaging applications. The system uniquely combines ... the features and flexibility of modern day ... unit.,The e.cam duet maximizes camera ...
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM...
... AXIOM Artis FA is ... C-arm system whose flexible ... for vascular and non-vascular ... provides complete ergonomic system ...
.60 x 22mm, angled 60, .33mm end port [Simcoe]...
Medicine Products: